Novyra Pharmachem Closes Trading Window for Q2 FY27 Results

Novyra Pharmachem Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended September 30, 2026. The decision aligns with SEBI regulations on insider trading, prohibiting Promoters, Directors, KMPs, Insiders, Designated Persons, Connected Persons, and their immediate relatives from trading during this period. The company will announce the date of the Board Meeting to approve these results in due course.